Insider Selling: LifePoint Hospitals Director Sells 1,000 Shares of Stock (LPNT)
LifePoint Hospitals (NASDAQ:LPNT) Director Richard H. Evans sold 1,000 shares of the stock on the open market in a transaction dated Thursday, June 12th. The stock was sold at an average price of $64.05, for a total transaction of $64,050.00. Following the sale, the director now directly owns 19,718 shares of the company’s stock, valued at approximately $1,262,938. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link.
Shares of LifePoint Hospitals (NASDAQ:LPNT) traded down 0.08% on Monday, hitting $64.33. The stock had a trading volume of 268,960 shares. LifePoint Hospitals has a 1-year low of $43.97 and a 1-year high of $65.07. The stock’s 50-day moving average is $59.96 and its 200-day moving average is $54.74. The company has a market cap of $2.861 billion and a P/E ratio of 23.17.
LifePoint Hospitals (NASDAQ:LPNT) last posted its quarterly earnings results on Friday, April 25th. The company reported $0.78 EPS for the quarter, beating the Thomson Reuters consensus estimate of $0.65 by $0.13. The company had revenue of $1.01 billion for the quarter, compared to the consensus estimate of $1,000.00 million. During the same quarter in the prior year, the company posted $0.79 earnings per share. The company’s quarterly revenue was up 8.2% on a year-over-year basis. Analysts expect that LifePoint Hospitals will post $2.70 EPS for the current fiscal year.
LPNT has been the subject of a number of recent research reports. Analysts at JPMorgan Chase & Co. reiterated an “overweight” rating on shares of LifePoint Hospitals in a research note on Tuesday, June 3rd. They now have a $65.00 price target on the stock, up previously from $62.00. Separately, analysts at Mizuho upgraded shares of LifePoint Hospitals from a “neutral” rating to a “buy” rating in a research note on Friday, May 30th. They now have a $72.00 price target on the stock, up previously from $58.00. Finally, analysts at FBR Capital Markets reiterated a “market perform” rating on shares of LifePoint Hospitals in a research note on Monday, April 28th. They now have a $58.00 price target on the stock. Seven equities research analysts have rated the stock with a hold rating and five have issued a buy rating to the stock. The stock presently has a consensus rating of “Hold” and an average price target of $61.25.
LifePoint Hospitals, Inc (NASDAQ:LPNT), through its subsidiaries, operates general acute care hospitals in non-urban communities in the United States.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.